Rheumatology Pharm Flashcards
Bind and block promoter sites of proinflammatory genes IL-1 alpha and IL-2 beta. Decreased production of tumor necrosis factor alpha
glucocorticoids
How do glucocorticoids make us more susceptible to infection?
decreases adherence of leukocytes to vascular endothelium
What cells that are part of the immune system do glucocorticoids increase the production of from the bone marrow?
neutrophils (decreases eosinohils, monocytes, lymphocytes, APCs)
What vaccines are contraindicated in a patient receiving chronic glucocorticoid therapy?
live vaccines (MMR, varicella, small pox)
What do you periodically need to monitor for in a patient receiving glucocorticoids?
BP, glucose, lipids, eye exam, bone density
Do steroids need dose adjustments in patients who have renal impairment?
nope!
What severity level of RA would a patient who has < 5 inflamed joints, no extraarticular dz, negative RF and anti-CCP antibody, and no evidence of erosions on xray?
mildly active
Initial treatment recommendations for mild RA and negative RF with good prognostic signs
hydroxycholoraquine
In terms of general drug classes, what can be used in addition to DMARDs for short term symptom management of RA?
NSAIDs or steroids until DMARDs have taken effect
What severity level of RA would a patient who has at least 5 inflamed joints, elevated ESR/CRP, positive RF and ACCP antibody, and radiographic evidence of disease be?
moderate to severly active RA
Initial treatment choice for a patient who has moderate to severely active RA
methotrexate
Treatment options for a patient who has moderate to severely active RA who is unable to tolerate methotrexate
TNF inhibitors such as Etanercept (Enbrel) or Adalimumab (Humira)
How long does it take for maximal results of RA therapy take effect?
3-6 months
What is the role of narcotic analgesics in RA?
no role unless end stage disease
Antimalarial agent that is used as a single agent with mild RA and no evidence of joint destruction and no inflammatory/autoimmune markers on labs. Usually used as add-on to methotrexate tx.
Hydroxychloroquine (Plaquenil)
Toxicity associated with Hydroxychloroquine (Plaquenil)
macular damage. Need eye exam every 6-12 months
Drug class that Hydroxychloroquine (Plaquenil) decreases the metabolism of (ie increases half-life making it more potent)
beta blockers (except atenolol and nadolol)
Drug that inhibits angiogenesis and decreases inflammatory cytokines and IgM RF production
sulfasalazine (Azulfidine)
Needed to break down sulfasalazine into sulfapyridine and 5-aminosalicylic acid
coliform bacteria
Toxicity associated with sulfasalazine
myelosuppression. Monitor with CBC every 3 months